AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools ...

Two recent developments in artificial intelligence (AI) and machine learning have the potential to accelerate product development by streamlining materials research. Israel-based MaterialsZone, a ...

DALLAS--(BUSINESS WIRE)-- Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology ...

The ability to anticipate what comes next has long been a competitive advantage -- one that's increasingly within reach for developers and organizations alike, thanks to modern cloud-based machine ...